Hospital Dia do Pulmao | Clinical Research Unit

Research site
Rua Engenheiro Paul Werner 1141, Blumenau, Santa Catarina, Brazil
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

The main purpose of the study is to evaluate the efficacy of vixarelimab compared with placebo on lung function in participants with idiopathic pulmo...

Systemic Sclerosis With Lung Involvement
Idiopathic Pulmonary Fibrosis
Drug: Vixarelimab
Drug: Placebo
Locations recently updated

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting
Lung Diseases, Interstitial
Drug: Placebo
Drug: BI 1015550

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

Trial conditions

Lung Diseases (3 trials)
Interstitial Lung Diseas... (2 trials)
COVID-19 (1 trial)
Chronic Obstructive Pulm... (1 trial)
Diffuse Scleroderma (1 trial)
Fibrosis (1 trial)
Idiopathic Pulmonary Fib... (1 trial)
Inflammation (1 trial)
Obstructive Lung Diseases (1 trial)
Pulmonary Fibrosis (1 trial)

And 2 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems